Impact of empagliflozin on diabetic kidney disease

    loading  Checking for direct PDF access through Ovid

Abstract

Empaglifolzin reduces metabolic derangements such as BP (blood pressure), hyperglycemia, body weight, uric acid, increases Ht (hamtaocrit), keton bodies, and restores altered tubule-glomerular feedback, thereby protect against diabetes-induced caidio-renal injuries.

    loading  Loading Related Articles